# Novel mRNA-based Urine Test for Bladder Cancer in Spinal Cord Injury Individuals

> **NCT02538809** · — · TERMINATED · sponsor: **Swiss Paraplegic Research, Nottwil** · enrollment: 50 (actual)

## Conditions studied

- Bladder Cancer
- Spinal Cord Injury

## Interventions

- **OTHER:** measurement of tumor mRNA concentration in urine

## Key facts

- **NCT ID:** NCT02538809
- **Lead sponsor:** Swiss Paraplegic Research, Nottwil
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2018-08-13
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 50 (ACTUAL)
- **Why stopped:** insufficient recruitment
- **Last updated:** 2025-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02538809

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02538809, "Novel mRNA-based Urine Test for Bladder Cancer in Spinal Cord Injury Individuals". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02538809. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*